LOS ANGELES, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Dave Inc. (“Dave” or the “Company”) (Nasdaq: DAVE), one of the nation’s leading neobanks, today announced that the Company will participate in three upcoming investor conferences in August 2024. Canaccord 44th …
Second Quarter 2024 Highlights: Revenue of $175.9 million, compared with $161.6 million in the same period last year GAAP net income of $14.9 million, or $0.25 per diluted share, compared with net loss of $85.3 million, or $1.61 loss per diluted share in …
Revenues increased 45% compared to the previous quarter ended March 31, 2024 Optimized LungFit PH device continues to expand footprint and strengthen customer base Amir Avniel, Beyond Air Board member and Chief Business Officer, appointed Chief Executive …
-- Advancing four clinical-stage programs for hematologic malignancies and autoimmune diseases; clinical data reports planned for 2024 and H1 2025 -- -- Enrolling 2L LBCL and prior CD19 relapsed LBCL patients based on CB-010 ANTLER Phase 1 data presented …
CHANDLER, Ariz., Aug. 06, 2024 (GLOBE NEWSWIRE) -- VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use of force training simulators and firearms training simulators for the law enforcement and military markets, …
DENVER, Aug. 06, 2024 (GLOBE NEWSWIRE) -- EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), a leading service commerce platform, today announced financial results for the quarter ended June 30, 2024. Second Quarter …
MELVILLE, N.Y., Aug. 06, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced that it will release its second …
Q2 GAAP EPS of $(0.01); Q2 Non-GAAP EPS of $0.07 OraQuick® HCV Self-test is the first globally to earn WHO pre-qualification Strong momentum with Syphilis Health Check™ launch Expanding Sample Management applications into saliva-based liquid biopsy …
RESTON, Va., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating media across platforms, today reported financial results for the quarter ended June 30, 2024. Q2 2024 Financial …
MILWAUKEE, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Weyco Group, Inc. (NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced financial results for the quarter ended June 30, 2024. Second Quarter 2024 Overview Net sales: $63.9 million (down 5% …
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral …
SAN FRANCISCO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that the Company will participate in the …
Increase in Net Revenue, Gross Profit, Gross Profit Margin, Net Income and Adjusted EBITDA Pre-Recorded Earnings Call Webcast Available on Investor Relations Website LAS VEGAS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods …
Company implementing significant cost reduction plan in the U.S. due to results in late-stage pamrevlumab pancreatic cancer trials, including a reduction of U.S. workforce by approximately 75% Focus R&D investment on FG-3246 and PET46, a first-in-class …
Q1 Financial Highlights: Revenue Increased Over 33% Year Over Year to $40 Million Reported Expanded Gross Margin and Achieved Non-GAAP Net Income Generated $3.4 Million of Operating Cash Flow Company to host conference call tomorrow, August 7th, at 10: …
NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Inter Parfums, Inc. (NASDAQ GS: IPAR) today reported results for the second quarter and six months ended June 30, 2024. Financial Highlights: ($ in millions, except per share amounts) Three Months Ended June 30, …
Completed enrollment in batoclimab pivotal Myasthenia Gravis (MG) trial; top-line results and initiation of a potentially registrational program for IMVT-1402 on track for fiscal year end (March 31, 2025) Progressed development of lead asset IMVT-1402 with …
Annualized recurring revenue (“ARR”) of $816 million, an increase of 9% year-over-year Total revenue of $208 million, up 9% year-over-year; Product subscriptions revenue of $200 million, up 10% year-over-year GAAP operating income of $7 million; non-GAAP …
MIAMI BEACH, FL, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Arogo Capital Acquisition Corp. (“Arogo” or the “Company”) (Nasdaq: AOGO/AOGOU/AOGOW), a special purpose acquisition company, today announced that it received a notice (the “Notice”) from the Listing …
DENVER, Aug. 06, 2024 (GLOBE NEWSWIRE) -- EverCommerce Inc. (Nasdaq: EVCM) (the “Company”), a leading provider of SaaS solutions for service SMBs, announced today that it has appointed Ryan Siurek as chief financial officer (CFO), effective September 6, …
